Drug Trial Radar · NCT02908100
A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
Last checked: Nov 19, 2026Latest source record: May 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
260
Actual
Start
Jan 19, 2017
Primary completion
May 28, 2019
Study completion Jul 16, 2019
Sponsor
- Lead sponsor
- Genentech, Inc.Roche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Sep 20, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study to evaluate the safety and efficacy of GDC-0853 in combination with standard of care therapy in participants with moderate to severe active systemic lupus erythematosus (SLE).
Conditions
- Systemic Lupus Erythematosus
Interventions
GDC-0853Drug
Participants received GDC-0853 at dosages of 150 or 200mg as per the dosing schedules described above.
PlaceboDrug
Participants received matching placebo to GDC-0853 at dosages of 150 and 200mg as per the dosing schedules described above.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Systemic Lupus Erythematosus Responder Index (SRI)-4 Response at Week 48Time frame: Week 48
Locations
70 sites in 12 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Valerius Medical Group & Research Ctr of Greater Long Beach
Los Alamitos, California
RASF-Clinical Research Center
Boca Raton, Florida
Bay Area Arthritis and Osteoporosis
Brandon, Florida
Omega Research Consultants
Orlando, Florida
Clinical Research of West Florida
Tampa, Florida
Institute of Arthritis Research
Idaho Falls, Idaho
Via Christi Research, a division of Via Christi Hospitals Wichita, Inc.
Wichita, Kansas
Ochsner Clinic Foundation
Baton Rouge, Louisiana
The Arthritis & Diabetes Clinic, Inc.; Research
Monroe, Louisiana
Albuquerque Clinical Trials
Albuquerque, New Mexico
Saint Lawrence Health System
Canton, New York
New York University School of Medicine
New York, New York
Shanahan Rheumatology & Immunology, PLLC
Raleigh, North Carolina
Ohio State University Clinical Trials Management Office
Columbus, Ohio
Tekton Research Inc
Austin, Texas
Accurate Clinical Research
Houston, Texas
Accurate Clinical Research
Houston, Texas
Arthritis Clinic Of Central Texas
San Marcos, Texas
Organizacion Medica de Investigacion
Buenos Aires, Argentina
APRILLUS
Buenos Aires, Argentina
Hospital Italiano de La Plata
La Plata, Argentina
CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica
San Juan, Argentina
Centro Medico Privado de Reumatologia; Reumathology
San Miguel, Argentina
CEDOES - Diagnóstico e Pesquisa
Vitória, Espírito Santo, Brazil
CIP - Centro Internacional de Pesquisa X; Pesquisa Clinica
Goiânia, Goiás, Brazil
Hospital das Clinicas - UFMG
Belo Horizonte, Minas Gerais, Brazil
CMiP - Centro Mineiro de Pesquisa*X*
Juiz de Fora, Minas Gerais, Brazil
Edumed - Educação e Saúde SA
Curitiba, Paraná, Brazil
Hospital Moinhos de Vento
Porto Alegre, Rio Grande do Sul, Brazil
Centro de Pesquisas em Diabetes - CPD
Porto Alegre, Rio Grande do Sul, Brazil
Clinica de Neoplasias Litoral
Itajaí, Santa Catarina, Brazil
Faculdade de Medicina do ABC - FMABC
Santo André, São Paulo, Brazil
Hospital Estadual Mario Covas
Santo André, São Paulo, Brazil
Hospital Abreu Sodré - AACD
São Paulo, São Paulo, Brazil
MHAT Plovdiv
Plovdiv, Bulgaria
Medical Center "Teodora", EOOD
Rousse, Bulgaria
Medical Center Excelsior OOD
Sofia, Bulgaria
UMHAT "Sv. Ivan Rilski", EAD
Sofia, Bulgaria
MC "Synexus - Sofia", EOOD
Sofia, Bulgaria
Showing 40 of 70 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.